Please use this identifier to cite or link to this item:
Title: Efficacy of Recombinase Polymerase Amplification to Diagnose Trypanosoma cruzi Infection in Dogs with Cardiac Alterations from an Endemic Area of Mexico
Other Titles: Eficacia de la amplificación de la polimerasa con recombinasa para diagnosticar la infección por Trypanosoma cruzi en perros con alteraciones cardíacas en un área endémica de México.
Authors: Jimenez-Coello, Matilde 
Shelite, Thomas 
Castellanos-Gonzalez, Alejandro 
Saldarriaga, Omar 
Rivero, Rocio 
Ortega-Pacheco, Antonio 
Acevedo-Arcique, Carlos 
Amaya-Guardia, Karla 
Garg, Nisha 
Melby, Peter 
Travi, Bruno L 
Keywords: Mexico;Enfermedad de Chagas;Trypanosoma cruzi;Diagnóstico;Perros;Prueba molecular
Issue Date: 2018
Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.) 
Chagas disease is a lingering Public Health problem in Latin America with ∼5.7 million people infected with Trypanosoma cruzi. Transmission is still taking place in most countries of the Americas, including the United States. Dogs are frequently infected with T. cruzi and its high infection prevalence is associated with increased risk of Chagas disease in humans. The city of Mérida in the Yucatan peninsula is endemic for Chagas disease and canines are frequently infected with T. cruzi. The objective of this study was to evaluate the performance of a qualitative point of care (POC) molecular test (RPA-LF, recombinase polymerase amplification-lateral flow) developed in our laboratory for identifying infected dogs. We used retrospective samples of dogs that came for consultation because of cardiac alterations and proved to be infected with T. cruzi as determined by enzyme-linked immunosorbent assay (ELISA), Western blot, and quantitative PCR (qPCR). The analytical sensitivity indicated that RPA-LF amplified T. cruzi DNA in samples containing almost equal to one to two parasites per reaction. Serial twofold dilutions of T. cruzi epimastigotes showed that the test had 95% (19/20) repeatability at concentrations of two parasites per reaction. The test showed no cross reactivity with human DNA or other protozoan parasites (Trypanosoma rangeli, Leishmania spp., and Plasmodium spp.). RPA-LF had the capacity to amplify all discrete typing units (DTUs I-VI) of T. cruzi that circulate in domestic or extradomestic environments. The RPA-LF had 93.2% (95% confidence interval 87.2-98.1) sensitivity and excellent agreement with qPCR used as gold standard (Cohen's Kappa test = 0.963). ELISA was positive in 96.6% (85/88) of dogs, which together with the molecular tests confirmed the frequent contact with infected triatomine bugs in the city of Mérida. These preliminary results on the diagnostic efficacy of the RPA-LF deserve further large-scale field testing of this POC test for T. cruzi infection in endemic areas.
DOI: 10.1089/vbz.2017.2258
Appears in Collections:Publicaciones INP

Show full item record

Page view(s)

checked on Jul 4, 2020

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.